Price transparency
What is disclosed before intake, not a clinical rating.
Arc-1 has current compounded semaglutide and tirzepatide product routes despite a general website-construction banner. Its official process describes checkout followed by online intake and a licensed practitioner’s prescribing assessment, with a zero-dollar consultation fee and shipping advertised as included. Both product categories start at $199.99 monthly, while selected-dose options differ in price. The public return policy is a general merchandise-style policy with exceptions, not a clearly established unconditional prescription refund. Obtain the actual clinical consent, dispenser, supply and cancellation terms before paying.
Arc-1 does not pay us. We review it so you can compare it with the programs that do. Disclosure
Public amounts require the selected preparation, complete payment and billing term to be confirmed.
On this page
Arc-1 at a glance
- Price visibility
- Public offer details
- Pharmacy information
- Not publicly named
- Where it operates
- Confirm clinical service and location eligibility. Semaglutide page excludes Arkansas, Indiana, Minnesota, Puerto Rico and South Carolina for that product; selected preparation and professional access need confirmation.
The verdict
Public amounts require the selected preparation, complete payment and billing term to be confirmed.
The score beside Arc-1's name rates how much it tells you before the medical intake — the price, the pharmacy and the terms — not how cheap it is.
Considering Arc-1?
Confirm the plan, billing terms and availability before you begin.
What do you get with Arc-1?
- An active product-selection route followed by a clinical intake after checkout. The current official treatment page describes independent practitioner review before a prescription can be fulfilled. Public availability supports a current entry point, but a selected product or completed purchase does not establish clinical approval or an entitlement to the requested dose.
- Compounded semaglutide and tirzepatide listed as separate prescription products. Each has different selected-dose options rather than one universal price for all doses. Ask the clinician for the prescribed preparation, ingredients, concentration, quantity and supplied period; the storefront’s chosen option should not replace an individualized prescription.
- A consultation described as having no separate fee and expedited shipping advertised within the product offer. Confirm the exact invoice, required evaluation, supplies and follow-up before comparing complete costs. The public monthly label does not by itself establish the shipped quantity or an unchanged continuing charge across future dose changes.
- A return-policy contact identity of Arc-1 Metrics PLLC, with professional evaluation described on the treatment pages. That return address does not establish every patient’s treating practice or dispensing pharmacy. Request the actual clinical and pharmacy identities in the consent and order rather than assigning a storefront supplier label to the individual prescription.
How does Arc-1 work?
Compare selected-dose prices and supplied quantity
The treatment cards begin at $199.99 monthly, while current selected-dose options have different amounts. Obtain the actual clinician-approved dose, quantity and supplied days before paying. Also ask whether another evaluation, required testing or delivery-related charge applies. A lowest-dose minimum is not a guarantee of the same expense through all future treatment stages.
Understand checkout before intake
The public process places checkout before the secure medical questionnaire. Ask when payment is authorized or collected and what happens if the practitioner declines treatment or recommends a different product. Confirm the professional practice and consent before sharing medical information. A zero-dollar consultation line does not by itself establish an unconditional refund of the full purchase.
Clarify the prescription-specific return rules
The product page advertises a thirty-day satisfaction policy, but the linked return document describes unused items, prior authorization and exceptions for custom or perishable goods. It does not clearly establish that dispensed prescription medicine can be returned or refunded on the same terms. Obtain the actual medication cancellation, clinical-decline and fulfillment policy before relying on the broad guarantee.
Confirm location access before fulfillment
The semaglutide page identifies specific excluded locations for that product. Those restrictions should be checked for the selected preparation rather than generalized to every possible service. Ask which practitioner treats the actual patient location and whether the pharmacy can supply the resulting prescription there. A national shipping description does not replace those clinical and dispensing checks.
How much does Arc-1 cost?
Compounded semaglutide from $199.99/month, with higher selected-dose options priced differently; actual complete continuing order needs confirmation; ongoing month-to-month total not established.
Compounded tirzepatide from $199.99/month, with higher selected-dose options priced differently; actual complete continuing order needs confirmation; ongoing month-to-month total not established.
Confirm clinical service and location eligibility. Semaglutide page excludes Arkansas, Indiana, Minnesota, Puerto Rico and South Carolina for that product; selected preparation and professional access need confirmation.
Both compounded treatment categories start at $199.99 monthly, with selected-dose options priced differently. The page advertises a zero-dollar consultation and included shipping, but the actual supplied quantity and continuing order require confirmation. Obtain the complete first payment, future charge and refund treatment if assessment does not lead to the requested prescription.
- Current selected-dose options have different prices. Do not treat the initial product-card minimum as a permanent price for all prescribed doses or as an instruction to choose a dose without clinician review.
- The product flow describes checkout before the clinical intake. Ask about authorization, collected payment and financial treatment if assessment leads to a decline or another recommendation.
- The thirty-day return language is not a clearly established prescription-specific money-back promise. The linked policy has unused-item requirements and exclusions that need clarification for medication.
- The general return policy says accepted refunds follow inspection and can take six to eight weeks. That timing should not be confused with a guaranteed right to return or refund a prescription order.
Considering Arc-1?
Confirm the plan, billing terms and availability before you begin.
Who is Arc-1 best for?
A good fit if
- Adults willing to review actual clinical terms before checkout
- People comparing the selected dose and supplied quantity
- Patients who clarify prescription-specific cancellation protections
Look elsewhere if
- Anyone expecting a construction banner to mean a closed service
- Shoppers relying on an unconditional prescription satisfaction refund
- People assuming the lowest-dose price applies to every option
Considering Arc-1?
Confirm the plan, billing terms and availability before you begin.
What are Arc-1's pros and cons?
Pros
- Current product routes describe an online prescribing assessment
- Consultation and shipping inclusions are stated
- Selected-dose options make variable pricing visible
Cons
- Clinical and dispensing assignments need individual confirmation
- Prescription-specific refund and decline rules need clarification
- Actual supply and later dose costs require the accepted order
The pharmacy behind the medicine
It does not name its pharmacy. Arc-1 does not publicly disclose which compounding pharmacy fills its prescriptions. That is common and it is not an accusation — but it does mean the one thing you would most want to verify about a compounded medicine is the one thing you cannot.
A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program, including the highest-scoring ones.
What else do people ask about Arc-1?
Is Arc-1 currently accepting product selections?
Current official prescription product routes expose available options and describe checkout followed by online intake. The general construction banner alone does not establish closure. Clinical suitability and fulfillment still depend on the practitioner and pharmacy, so confirm the selected order before paying.
Does $199.99 apply at every dose?
That is a starting amount for the listed compounded products. Selected-dose options have different prices. Ask for the clinician-approved prescription, quantity and supplied period, along with the next order price, rather than assuming the minimum covers all continuing treatment.
When does the clinical assessment happen?
The product page describes completing checkout first, then providing information through the secure intake for practitioner review. Confirm payment timing, the treating practice and what happens financially if the requested prescription is declined or changed before authorizing the transaction.
Is the thirty-day guarantee an unconditional medication refund?
The linked policy describes general returns with unused-item requirements and exceptions, not a clear universal prescription refund. Ask for the actual treatment-decline, cancellation and pharmacy-processing rules. Do not assume dispensed medicine can be returned under ordinary merchandise terms.
Which pharmacy fills the prescription?
A universally assigned dispenser was not established from the reviewed public treatment and policy pages. Obtain the actual pharmacy name, preparation and instructions in the prescription order. A storefront supplier label or general licensed-pharmacy claim does not establish that individual assignment.
Is the treatment available everywhere?
The semaglutide page specifically excludes Arkansas, Indiana, Minnesota, Puerto Rico and South Carolina for that product. Confirm the selected preparation, actual patient location and practitioner authorization. A restriction on one product should not automatically be applied to every other service.
Sources for this review
Company information and terms used for this review. These sources describe the service; they do not establish treatment outcomes.
How it compares
Arc-1 ranks 111 of 358 on our price-transparency score. Every prescription GLP-1 program we review is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.
Because Arc-1 shows a price before the intake, it is also ranked on our GLP-1 telehealth ranking.
Compounded semaglutide program advertised at $299/month including medication and standard labs; renewal notice and selected agreement need confirmation; ongoing month-to-month total not established.Show the full pricing note
One-month compounded semaglutide listed at $215 or three months at $600; complete accepted plan needs confirmation; ongoing month-to-month total not established.Show the full pricing note
General GLP-1 care from $199 without a complete semaglutide-specific supply and renewal quote; shipping may be separate; ongoing month-to-month total not established.Show the full pricing note
Semaglutide + B6 $129/month within a 90-day protocol, three-month supply; independent ongoing month-to-month total not established.Show the full pricing note
Official semaglutide offer starts at $125; supply/dose/renewal qualifications unresolved; Nevada excluded; ongoing month-to-month total not established.Show the full pricing note
Read this before you start
Prices change — confirm on Arc-1's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.